IRIS
PINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.197
EU - Europa 9.137
AS - Asia 4.292
SA - Sud America 694
Continente sconosciuto - Info sul continente non disponibili 294
AF - Africa 221
OC - Oceania 19
Totale 24.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.034
GB - Regno Unito 1.965
IT - Italia 1.903
RU - Federazione Russa 1.623
CN - Cina 1.522
SG - Singapore 1.238
IE - Irlanda 977
SE - Svezia 637
BR - Brasile 537
UA - Ucraina 527
DE - Germania 492
VN - Vietnam 433
FR - Francia 398
HK - Hong Kong 324
KR - Corea 238
FI - Finlandia 221
IN - India 139
ZA - Sudafrica 126
BD - Bangladesh 97
ES - Italia 83
CA - Canada 82
PL - Polonia 64
BE - Belgio 59
NL - Olanda 53
AR - Argentina 51
PK - Pakistan 40
JP - Giappone 39
MX - Messico 36
TR - Turchia 36
AT - Austria 26
CZ - Repubblica Ceca 24
IR - Iran 24
VE - Venezuela 22
CO - Colombia 21
EC - Ecuador 20
NG - Nigeria 19
CL - Cile 18
IQ - Iraq 18
AU - Australia 16
CH - Svizzera 16
KE - Kenya 16
PH - Filippine 14
UZ - Uzbekistan 13
AZ - Azerbaigian 12
CI - Costa d'Avorio 12
EU - Europa 11
LT - Lituania 11
RO - Romania 11
DZ - Algeria 10
EG - Egitto 10
ID - Indonesia 10
IL - Israele 10
JO - Giordania 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
MY - Malesia 9
PE - Perù 9
SA - Arabia Saudita 9
TN - Tunisia 9
CR - Costa Rica 8
MA - Marocco 8
DK - Danimarca 7
PY - Paraguay 7
TW - Taiwan 7
BO - Bolivia 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
ET - Etiopia 5
JM - Giamaica 5
BG - Bulgaria 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BS - Bahamas 3
GD - Grenada 3
GR - Grecia 3
GY - Guiana 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
SI - Slovenia 2
TH - Thailandia 2
AO - Angola 1
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
Totale 24.554
Salva come PNG Salva come JPEG
Città #
Southend 1.750
Dallas 1.064
Dublin 965
Fairfield 778
Ashburn 754
Singapore 677
Chandler 554
Siena 483
Moscow 461
San Jose 452
Santa Clara 434
Jacksonville 428
Woodbridge 400
Beijing 384
Milan 372
Ann Arbor 349
Seattle 329
Wilmington 321
Houston 310
Hong Kong 302
Hefei 287
Council Bluffs 264
Menlo Park 260
Cambridge 247
Seoul 234
Los Angeles 180
Princeton 172
New York 158
Rome 154
The Dalles 147
Nanjing 133
Johannesburg 120
Ho Chi Minh City 105
Florence 99
Helsinki 96
Munich 94
Lauterbourg 93
Dong Ket 87
Boardman 84
Hanoi 79
San Mateo 67
Buffalo 62
Shanghai 61
Málaga 60
Nanchang 56
Columbus 54
San Diego 52
São Paulo 52
Dearborn 42
Fremont 42
Orem 41
Shenyang 41
London 39
Bengaluru 37
Brussels 37
Chicago 37
Warsaw 35
Hebei 34
Turku 34
Brooklyn 31
Redwood City 29
Toronto 28
Phoenix 27
Washington 27
Figino 26
Frankfurt am Main 26
Tokyo 26
Tianjin 25
Atlanta 24
Chennai 24
Kunming 24
Montreal 24
Redondo Beach 24
Stockholm 23
Turin 22
Bagno a Ripoli 21
Changsha 21
Da Nang 21
Porto Alegre 21
Dhaka 20
San Francisco 20
Abuja 19
Brno 19
Denver 19
Nuremberg 19
Amsterdam 18
Düsseldorf 18
Naples 18
Guangzhou 17
Jiaxing 17
Vienna 17
Belo Horizonte 16
Lappeenranta 16
Manchester 16
Ningbo 16
Boston 15
Hangzhou 15
Izmir 15
Kansas City 15
Paris 15
Totale 16.397
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 388
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 379
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 376
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 373
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 359
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 348
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 342
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 333
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 320
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 320
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 319
A new NT4 peptide-based drug delivery system for cancer treatment 316
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 314
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 311
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 309
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 309
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 305
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 303
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 298
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 296
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 288
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 287
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 283
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 282
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 282
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 279
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 278
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 275
Branched peptides as bioactive molecules for drug design 274
Tumor imaging with tetrabranched neurotensin 273
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 268
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 263
Antibacterial peptides and analogues thereof 262
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 261
Branched Neurotensin For Tumor Targeting 260
Bioactive peptides from libraries 258
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 258
Branched peptides for tumor diagnosis and therapy 252
Esculentin-1a-derived peptides promote clearance of pseudomonas aeruginosa internalized in bronchial cells of cystic fibrosis patients and lung cell migration: Biochemical properties and a plausible mode of action 250
Branched peptides as targeting agents for tumor imaging and therapy 247
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 247
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 245
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 242
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 241
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 238
Branched Neurotensin peptides for tumor personalized therapy 238
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 235
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 233
Branched peptides as therapeutics 232
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 230
Branched multimeric peptides for tumor diagnosis and therapy 229
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 228
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 227
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 227
Synthetic peptides in the form of dendrimers become resistant to protease activity 224
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 224
The antimicrobial peptide M33. An example of drug development 221
The development of antimicrobial peptides as new antibacterial drugs 221
ANTICORPI E PEPTIDI -I farmaci del XXI secolo- 220
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 217
Branched neurotensin for tumor targeting 217
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 217
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 217
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 213
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 212
Tumor selective targeting by branched peptides 212
Molecular basis of branched peptides resistance to enzyme proteolysis 208
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 206
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 204
Phage display and colony filter screening for high-throughput selection of antibody libraries 200
Neurotensin-derived branched peptides and uses thereof 198
COMPOSTI ANTI TNF-ALPHA E LORO USI 194
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 189
Synthetic antidotes against snake neurotoxins 188
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 187
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 185
Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded 183
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform 183
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 180
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 177
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa 176
Tumor imaging with tetrabranched neurotensin 176
The antimicrobial peptide M33. An example of drug development 173
Branched neurotensin peptides for tumor targeting 173
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 169
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 168
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 167
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 166
Dendrimeric peptides for tumor targeting 166
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 165
Strategies for the construction and use of peptide and antibody libraries displayed on phages. 162
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 160
Peptide sequences, their branched form and use thereof for antimicrobial applications 157
Phage display of antibody fragments 156
Synthetic inhibitors of anthrax lethal toxin 154
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases 152
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 151
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 151
Synthetic peptides in the form of dendrimers can become resistant to protease activity 146
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 142
Totale 23.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.232 0 0 96 157 93 62 60 78 58 165 171 292
2022/20232.050 114 207 253 279 221 384 50 161 170 85 87 39
2023/20241.572 51 49 130 77 69 440 550 34 8 35 20 109
2024/20253.193 72 140 358 185 390 181 126 200 241 119 331 850
2025/20268.058 565 1.040 846 930 1.470 312 846 261 331 480 257 720
2026/2027720 354 228 138 0 0 0 0 0 0 0 0 0
Totale 24.854